Market Tracker

06/30 4:04am ET

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

39.86
Delayed Data
As of Jun 29
 -2.07 / -4.94%
Today’s Change
19.21
Today|||52-Week Range
46.48
+25.54%
Year-to-Date
No recent news for ACADIA Pharmaceuticals Inc.

Today’s Trading

Previous close41.93
Today’s open41.40
Day’s range-- - --
Volume1,099,316
Average volume (3 months)1,241,113
Market cap$4.2B
Dividend yield--
Data as of 06/29/2015

Growth & Valuation

Earnings growth (last year)-115.91%
Earnings growth (this year)-44.61%
Earnings growth (next 5 years)--
Revenue growth (last year)-89.52%
P/E ratioNM
Price/Sales25,730.20
Price/Book13.55

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA-0.01-0.03%
NBIXNeurocrine Bioscienc...-0.91-1.95%
PBYIPuma Biotechnology I...-2.18-1.88%
RAREUltragenyx Pharmaceu...-4.72-4.58%
Data as of 06/29/2015

Financials

Next reporting dateAugust 4, 2015
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$120.0K
Annual profit (last year)-$92.5M
Net profit margin-77,062.50%

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Chief Business Officer &
Executive VP
Stephen R. Davis
Chief Medical Officer &
Executive VP-Development
Roger G. Mills
Corporate headquarters
San Diego, California

Forecasts